Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02252120
Other study ID # Schulthess_Anä_4
Secondary ID
Status Completed
Phase N/A
First received September 17, 2014
Last updated September 26, 2014
Start date January 2014
Est. completion date September 2014

Study information

Verified date September 2014
Source Schulthess Klinik
Contact n/a
Is FDA regulated No
Health authority Austria : Federal Ministry for Labour, Health, and Social Affairs
Study type Interventional

Clinical Trial Summary

The investigators test the hypothesis that oropharyngeal leak pressure and fiberoptic position differ between the size 2 LMA SupremeTM and the Laryngeal Tube LTS IITM in non-paralyzed anaesthetized pediatric patients


Description:

The Laryngeal Tube LTS IITM (VBM-Medizintechnik GmbH, Sulz a.N, Germany) is a well established reusable latex free, extraglottic airway device. A proximal (pharyngeal) and a distal (esophageal) cuff are inflated with a single cuff pilot line. In between lies the ventilation orifice. The LMA SupremeTM (Teleflex San Diego, CA, USA) is a single use well studied laryngeal mask airway. Both devices have a drain tube to allow access to the gastrointestinal tract. Actually there are no studies comparing Laryngeal Tube LTS IITM and LMA SupremeTM use in small children. Therefore the aim of this study was to evaluate the clinical performance of the Laryngeal Tube LTS IITM compared to the LMA SupremeTM. The investigators hypothesized that design differences should lead to differences in efficacy of seal and anatomic position. In this randomized, crossover study, the investigators test the hypothesis that in non-paralyzed pediatric patients the oropharyngeal leak pressure and fiberoptic position differs between the size 2 Laryngeal Tube LTS IITM and the LMA SupremeTM.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Months to 9 Years
Eligibility Inclusion Criteria:

- ASA I-II

- age 1.5 - 9 years

- minor surgery

- extraglottic airway device

Exclusion Criteria:

- age (<18 months, >9 years)

- weight (<10 kg, >25 kg)

- a known difficult airway

- risk of aspiration

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Supreme

Laryngeal Tube


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Schulthess Klinik University of Salzburg

Outcome

Type Measure Description Time frame Safety issue
Other Ease of insertion We allowed one attempt before considering a failure, defining failed insertion by any of the following criteria:
1) failed passage into the pharynx; 2) malposition (air leaks); and 3) ineffective ventilation (maximum expired tidal volume <4 ml kg-1 or end-tidal CO2 > 50 mm Hg (if correctly positioned). ). Insertion time was defined as the interval between picking up the prepared device and successfully placement. After placement effective ventilation was tested by observation of chest wall movement and capnometric curve trace. If insertion failed the etiology was signed on the CRF. After a first insertion attempt one single attempt with the guiding technique was allowed.
1 Min Yes
Primary Oropharyngeal leak pressure Oropharyngeal leak pressure was determined by closing the expiratory valve of the anaesthesia breathing system and a fixed gas flow of 3 l minute-1. The airway pressure at which an equilibrium was reached was noted (maximum allowed 40 cm H2O). 5 Min Yes
Secondary Fiberoptic position The airway tube view was scored using an established scoring system (4=only vocal cords visible; 3=vocal cords plus posterior epiglottis; 2=vocal cords plus anterior epiglottis; 1=vocal cords not seen) 5 Min Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01350076 - Liberal Versus Goal-directed Intraoperative Fluid Therapy in Pediatric Patients Phase 2
Withdrawn NCT02121951 - Quadratus Lumborum Block for Percutaneous Nephrostomy Phase 4
Not yet recruiting NCT02977559 - A Study Between the Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Pediatric Patients N/A
Completed NCT01575236 - A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway Phase 3
Recruiting NCT01898897 - Influence of Anesthesia Technique on Postoperative Evolution After Urogenital Surgical Interventions N/A
Completed NCT03015857 - Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension Phase 2
Completed NCT02884986 - Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor N/A
Completed NCT02856672 - Trial Comparing the Laryngeal Tube Suction Disposable and the Supreme Laryngeal Mask Airway N/A
Completed NCT02859922 - Comparison Between the Supreme Laryngeal Mask Airway and the Laryngeal Tube Suction During Spontaneous Ventilation N/A
Completed NCT00468598 - The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery N/A
Recruiting NCT02883192 - The Effect of Preventive Use of Ondansetron in the Cesarean Section Under Spinal Anesthesia N/A
Not yet recruiting NCT02866890 - The New Laryngeal Tube Suction-Disposable for Childrens N/A
Completed NCT02570269 - Prospective Comparison of Oral Intubation Via - Ambu® Aura Gain™ vs Slotted Guedel Tubus N/A
Not yet recruiting NCT02884869 - Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Mask Airway N/A
Not yet recruiting NCT02884843 - The New Intubating Laryngeal Tube Suction-Disposable N/A
Not yet recruiting NCT02884895 - A Comparison of Direct Laryngoscopy With Blind Intubation Via Intubating Laryngeal Tube Suction Disposable N/A
Completed NCT02884921 - Preemptive Analgesia Using Intravenous Paracetamol N/A